Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
about
Estrogen and xenoestrogens in breast cancerXenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cellsPlant sterols as anticancer nutrients: evidence for their role in breast cancerThe molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityRole of the modulation of CYP1A1 expression and activity in chemopreventionRaloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cellsHop (Humulus lupulus L.) extract and 6-prenylnaringenin induce P450 1A1 catalyzed estrogen 2-hydroxylationCYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control studyLiquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications.Predicting environmental chemical factors associated with disease-related gene expression dataMechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens.The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China.Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines.SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesMorphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptorsRoles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor statusAssociation between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.Body burdens of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls and their relations to estrogen metabolism in pregnant womenReactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cellsIMS updated recommendations on postmenopausal hormone therapy.Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.Potential mechanisms of estrogen quinone carcinogenesis.Urine biomarkers of risk in the molecular etiology of breast cancer.Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis.Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fosCatechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells.Stress and breast cancer: from epidemiology to molecular biology.Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol.Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.The molecular etiology of breast cancer: evidence from biomarkers of risk.Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A).The role of the basal stem cell of the human breast in normal development and cancer.Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol
P2860
Q24605175-FF2E2D72-EB11-46DE-B049-8F165AD3F49CQ24634687-A3373275-EA22-4B00-911A-739E3F0A36EFQ26861053-E478FAE5-DA84-4057-B2C3-264D34C21BADQ27021258-4A4BDF59-79A7-4E88-AFCA-12A4CD461DCCQ28307748-12A18D05-C416-4356-8EB4-E1E3A5339E94Q28478183-CE58A7B0-C5E4-41C8-9C21-82D167C5A438Q28829558-5239DEB5-5F99-4505-921C-0127D156D72DQ33432351-ED258174-BF7E-424B-BDCC-31B57A8293CCQ33444906-32A47074-243D-4300-ACC5-0A671E69F02CQ33575070-332DD0AB-FC1C-486A-878A-9A660C9F5EE3Q33623628-268F9269-159D-43D1-9156-2827BCB09721Q33888802-88D6F95D-B60A-4CA6-845D-94FE1F1F8C43Q33901405-BAF1552C-A404-4D64-ACE4-194C5AF9FBBAQ34024966-68BC7965-5FBF-4B18-861F-E6DFE0CF7D53Q34114041-C0FB7037-F611-4D69-8FA4-2AB0E2442918Q34119028-00091EA9-0CB4-4A1A-B7E8-9353B3294999Q34148850-A85C0324-1CCB-476A-8F43-9E41F6548962Q34213076-957E23E7-2D15-4451-867C-8F6DA1131AEDQ34333680-83C9FFB1-7F8F-4D7F-B66D-55492798DDCEQ34440985-145F5FCE-D85D-48F7-BF9A-381739A2D07DQ34508226-72CB819B-0102-4D6A-9112-54A17D150425Q34521954-DA48A0E5-0C44-4BC5-B8B6-8D53EF249FE0Q34598054-83DA91EF-0598-425A-8869-E486CBD58380Q34626471-E71D46DC-695C-4E18-B363-6796978B517AQ34640104-79999B16-52BB-4416-989F-66023C086BEDQ34720369-89CC26B7-46C8-4BFA-A5D7-79A80E3CFED7Q34908964-EDE950EA-5F96-4B1C-B03A-CD3C692E0049Q35010154-D7B9812B-3A2A-4F8B-BD5B-53B642C6D7DDQ35121907-8E594AFA-3AA8-47A5-BDAF-7A7686C4ED26Q35144535-F48C9D46-89F7-4125-A0B5-C9AFBE3AAA16Q35558923-E7FEFC54-27DA-490D-B80C-BA857C51E08DQ35575581-D1CA7735-A813-40F8-B047-E40DA1027C05Q35575724-EDEE7941-73DB-49CB-8B1D-7A7166984F3DQ35576611-2499ACFA-DFB7-4040-8F1D-6249CD5EC55FQ35580183-1768154A-FBCB-43B6-90D0-64CC887CDF9AQ35586131-92396CC7-D77E-4D25-AD6B-DE6BDFB0548EQ35593300-EFDA0F89-B5A9-4F45-985A-7C0F9BF73011Q35656216-A42B0466-7FE3-4E8F-B513-04DE8733BAA6Q35669146-A28FB4CB-3015-4421-BF93-437315486EB1Q35671133-46B2A2F5-FC9A-43F4-8FA5-FB6CEB4B97FA
P2860
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
@ast
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
@en
type
label
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
@ast
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
@en
prefLabel
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
@ast
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
@en
P2093
P1476
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
@en
P2093
Irma H Russo
Jose Russo
M Hasan Lareef
Shanchun Guo
P356
10.1016/S0960-0760(03)00390-X
P50
P577
2003-10-01T00:00:00Z